JP2007530579A - アミド置換イミダゾピリジン、イミダゾキノリン、およびイミダゾナフチリジン - Google Patents

アミド置換イミダゾピリジン、イミダゾキノリン、およびイミダゾナフチリジン Download PDF

Info

Publication number
JP2007530579A
JP2007530579A JP2007505186A JP2007505186A JP2007530579A JP 2007530579 A JP2007530579 A JP 2007530579A JP 2007505186 A JP2007505186 A JP 2007505186A JP 2007505186 A JP2007505186 A JP 2007505186A JP 2007530579 A JP2007530579 A JP 2007530579A
Authority
JP
Japan
Prior art keywords
group
alkyl
alkylene
heterocyclyl
heteroaryl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2007505186A
Other languages
English (en)
Japanese (ja)
Other versions
JP2007530579A5 (https=
Inventor
アール． クレプスキー，ラリー
エフ．，ジュニア デラリア，ジョセフ
イー． ダフィー，ダニエル
ティー． アモス，デイビッド
エム． ジンマーマン，バーンハルト
エイチ． モザー，ウィリアム
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
3M Innovative Properties Co
Original Assignee
3M Innovative Properties Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 3M Innovative Properties Co filed Critical 3M Innovative Properties Co
Priority claimed from PCT/US2005/009880 external-priority patent/WO2005094531A2/en
Publication of JP2007530579A publication Critical patent/JP2007530579A/ja
Publication of JP2007530579A5 publication Critical patent/JP2007530579A5/ja
Pending legal-status Critical Current

Links

Classifications

    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
JP2007505186A 2004-06-10 2005-03-24 アミド置換イミダゾピリジン、イミダゾキノリン、およびイミダゾナフチリジン Pending JP2007530579A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US57876904P 2004-06-10 2004-06-10
PCT/US2005/009880 WO2005094531A2 (en) 2004-03-24 2005-03-24 Amide substituted imidazopyridines, imidazoquinolines, and imidazonaphthyridines

Publications (2)

Publication Number Publication Date
JP2007530579A true JP2007530579A (ja) 2007-11-01
JP2007530579A5 JP2007530579A5 (https=) 2008-05-08

Family

ID=38769911

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2007505186A Pending JP2007530579A (ja) 2004-06-10 2005-03-24 アミド置換イミダゾピリジン、イミダゾキノリン、およびイミダゾナフチリジン

Country Status (1)

Country Link
JP (1) JP2007530579A (https=)

Cited By (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2015166370A (ja) * 2008-03-19 2015-09-24 オーリムメッド・ファルマ・インコーポレーテッド 中枢神経系疾患および障害の治療に有効な新規化合物
JP2015530377A (ja) * 2012-08-24 2015-10-15 グラクソスミスクライン・リミテッド・ライアビリティ・カンパニーＧｌａｘｏＳｍｉｔｈＫｌｉｎｅ ＬＬＣ ピラゾロピリミジン化合物
JP2020508302A (ja) * 2017-02-17 2020-03-19 イネイト・テューマー・イミュニティ・インコーポレイテッドＩｎｎａｔｅ Ｔｕｍｏｒ Ｉｍｍｕｎｉｔｙ， Ｉｎｃ． Ｎｌｒｐ３修飾因子としての置換されたイミダゾキノリン類
US10793515B2 (en) 2008-03-19 2020-10-06 Aurimmed Pharma, Inc. Compounds advantageous in the treatment of central nervous system diseases and disorders
JP2023533961A (ja) * 2020-07-08 2023-08-07 パーデュー・リサーチ・ファウンデーション 線維性疾患およびがんを処置するための化合物、組成物、および方法
US12486218B2 (en) 2008-03-19 2025-12-02 Aurimmed Pharma, Inc. Compounds advantageous in the treatment of central nervous system diseases and disorders

Cited By (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2015166370A (ja) * 2008-03-19 2015-09-24 オーリムメッド・ファルマ・インコーポレーテッド 中枢神経系疾患および障害の治療に有効な新規化合物
JP2017214399A (ja) * 2008-03-19 2017-12-07 オーリムメッド・ファルマ・インコーポレーテッド 中枢神経系疾患および障害の治療に有効な新規化合物
US10793515B2 (en) 2008-03-19 2020-10-06 Aurimmed Pharma, Inc. Compounds advantageous in the treatment of central nervous system diseases and disorders
US12486218B2 (en) 2008-03-19 2025-12-02 Aurimmed Pharma, Inc. Compounds advantageous in the treatment of central nervous system diseases and disorders
JP2015530377A (ja) * 2012-08-24 2015-10-15 グラクソスミスクライン・リミテッド・ライアビリティ・カンパニーＧｌａｘｏＳｍｉｔｈＫｌｉｎｅ ＬＬＣ ピラゾロピリミジン化合物
JP2020508302A (ja) * 2017-02-17 2020-03-19 イネイト・テューマー・イミュニティ・インコーポレイテッドＩｎｎａｔｅ Ｔｕｍｏｒ Ｉｍｍｕｎｉｔｙ， Ｉｎｃ． Ｎｌｒｐ３修飾因子としての置換されたイミダゾキノリン類
JP7003143B2 (ja) 2017-02-17 2022-01-20 イネイト・テューマー・イミュニティ・インコーポレイテッド Ｎｌｒｐ３修飾因子としての置換されたイミダゾキノリン類
JP7003143B6 (ja) 2017-02-17 2024-02-26 イネイト・テューマー・イミュニティ・インコーポレイテッド Ｎｌｒｐ３修飾因子としての置換されたイミダゾキノリン類
JP2023533961A (ja) * 2020-07-08 2023-08-07 パーデュー・リサーチ・ファウンデーション 線維性疾患およびがんを処置するための化合物、組成物、および方法

Similar Documents

Publication Publication Date Title
US8697873B2 (en) Amide substituted imidazopyridines, imidazoquinolines, and imidazonaphthyridines
US8802853B2 (en) Arylalkenyl and arylalkynyl substituted imidazoquinolines
US7939526B2 (en) Sulfone substituted imidazo ring ethers
US8735421B2 (en) Imidazoquinolinyl sulfonamides
JP4891088B2 (ja) 置換されたイミダゾ環系および方法
EP1851220A2 (en) Hydroxyalkyl substituted imidazonaphthyridines
WO2005123080A2 (en) Nitrogen-containing heterocyclyl substituted imidazoquinolines and imidazonaphthyridines
EP1850849A2 (en) Method of preferentially inducing the biosynthesis of interferon
WO2006093514A2 (en) Aryl and arylalkylenyl substituted thiazoloquinolines and thiazolonaphthyridines
WO2006009826A1 (en) Aryloxy and arylalkyleneoxy substituted thiazoloquinolines and thiazolonaphthyridines
EP1653955A2 (en) Hydroxylamine substituted imidazo-containing compounds
WO2006065280A2 (en) Isoxazole, dihydroisoxazole, and oxadiazole substituted imidazo ring compounds and methods
WO2005123079A2 (en) Urea substituted imidazopyridines, imidazoquinolines, and imidazonaphthyridines
JP2008511683A (ja) ２−アミノ１ｈ−イミダゾ環構造および方法
US9550773B2 (en) Substituted imidazoquinolines, imidazopyridines, and imidazonaphthyridines
JP2007530579A (ja) アミド置換イミダゾピリジン、イミダゾキノリン、およびイミダゾナフチリジン

Legal Events

Date Code Title Description
A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20080321

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20080321

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20110628

A02 Decision of refusal

Free format text: JAPANESE INTERMEDIATE CODE: A02

Effective date: 20111220